<code id='0A25D5663B'></code><style id='0A25D5663B'></style>
    • <acronym id='0A25D5663B'></acronym>
      <center id='0A25D5663B'><center id='0A25D5663B'><tfoot id='0A25D5663B'></tfoot></center><abbr id='0A25D5663B'><dir id='0A25D5663B'><tfoot id='0A25D5663B'></tfoot><noframes id='0A25D5663B'>

    • <optgroup id='0A25D5663B'><strike id='0A25D5663B'><sup id='0A25D5663B'></sup></strike><code id='0A25D5663B'></code></optgroup>
        1. <b id='0A25D5663B'><label id='0A25D5663B'><select id='0A25D5663B'><dt id='0A25D5663B'><span id='0A25D5663B'></span></dt></select></label></b><u id='0A25D5663B'></u>
          <i id='0A25D5663B'><strike id='0A25D5663B'><tt id='0A25D5663B'><pre id='0A25D5663B'></pre></tt></strike></i>

          explore

          explore

          author:explore    Page View:718
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

          Home health and hospice chain Amedisys has chosen a new corporate owner.

          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

          advertisement

          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more
          Smaller biotechs seek to piggyback on weight loss drug boom
          Smaller biotechs seek to piggyback on weight loss drug boom

          SuzanneKreiterGlobestaffThestate’scelebratedclusterofbiotechshashatchedbreakthroughmedicinesforevery

          read more
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more

          Merck, Daiichi strike cancer drug pact worth up to $22 billion

          KenaBetancur/GettyImagesMADRID—MerckispayingbillionsofdollarstopartnerwithDaiichiSankyoonaseriesofca